XXEC Inc’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,425
Closed -$3.13M 22
2024
Q2
$3.13M Sell
6,425
-100
-2% -$50.2K 2.42% 19
2024
Q1
$3.52M Hold
6,525
2.65% 19
2023
Q4
$3.62M Sell
6,525
-185
-3% -$86.9K 2.85% 16
2023
Q3
$2.93M Sell
6,710
-170
-2% -$84.8K 2.48% 20
2023
Q2
$3.46M Sell
6,880
-150
-2% -$71.9K 2.64% 21
2023
Q1
$3.52M Sell
7,030
-170
-2% -$81.4K 2.81% 18
2022
Q4
$2.94M Buy
+7,200
New +$2.79M 2.35% 20

Other funds holding IDXX

XXEC Inc's IDXX Position: Q3 2024 in Review

XXEC Inc sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 6,425 shares — an estimated $3.13M sold.

XXEC Inc first reported a position in IDXX in Q4 2022 and held it in 7 quarters. The position peaked at $3.62M in Q4 2023. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • XXEC Inc reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • XXEC Inc sold 6,425 Idexx Laboratories shares in Q3 2024, an estimated $3.13M.
  • XXEC Inc first reported a position in Idexx Laboratories in Q4 2022 and held it in 7 quarters.
  • XXEC Inc's Idexx Laboratories position peaked at $3.62M in Q4 2023.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on XXEC Inc's 13F filing for Q3 2024, filed 5 Nov 2024.